Growth in innovative, value-based contracts holds promise for the health system and for patients

The extraordinary financial pressure COVID-19 is creating for the U.S. economy underscores the need for a renewed push toward a more value-driven health care system that prioritizes patient access and affordability. Now more than ever, we need to make sure we ’re spending our health resources wisely. That’s why it’s heartening to see the number of innovative contracts grow between biopharmaceutical companies and insurance companies as potential solutions for better affordability and better outcomes.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Access Value-Driven Health Care The Value Collaborative Source Type: news